Selvas Healthcare amends semiannual report to disclose 22,985 treasury shares held as of June 30, 2026

By Public Technologies
  • Selvas Healthcare issued a corrected semi-annual report for H1 2026 to add previously omitted treasury stock disclosures.
  • Treasury stock holdings totaled 22,985 common shares as of June 30, 2026, equal to 0.09% of shares outstanding.
  • Breakdown showed 22,400 shares held for share-price support and shareholder value enhancement, plus 585 shares acquired from a 2017 share consolidation.
  • No treasury stock purchases, sales, or cancellations were reported during the period.
  • Statutory cancellation deadline was cited as September 5, 2027; disposal or cancellation plans were not finalized.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Selvas Healthcare Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260930000205), on September 30, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.